Maxigen Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	576.19	639.05	431.08	790.95	513.31
Short-Term Investments	300	-	-	8.82	13.84
Cash & Short-Term Investments	876.19	639.05	431.08	799.76	527.15
Cash Growth	37.11%	48.24%	-46.10%	51.72%	151.31%
Accounts Receivable	132.19	103.91	88.31	98.86	109.95
Other Receivables	-	-	8.75	1.42	4.76
Receivables	132.19	103.91	97.06	100.27	114.71
Inventory	99.19	75.76	85.32	75.41	80.63
Prepaid Expenses	11.97	9.82	4.52	15.41	47.78
Other Current Assets	1.93	1.79	1.58	2.39	13.29
Total Current Assets	1,121	830.33	619.56	993.25	783.55
Property, Plant & Equipment	442.83	430.36	424.18	434.62	465.45
Long-Term Investments	279.68	311.31	432.8	-	-
Other Intangible Assets	0.73	0.13	0.49	1.16	1.83
Long-Term Deferred Tax Assets	1.13	2.55	5.83	3.19	0.38
Other Long-Term Assets	47.31	7.81	10.13	15.5	13.97
Total Assets	1,893	1,582	1,493	1,448	1,265
Accounts Payable	88.22	49.98	17.17	35.94	40.15
Accrued Expenses	83.11	72.07	64.63	55.35	40.35
Short-Term Debt	100	-	-	-	-
Current Portion of Leases	-	-	-	-	2.36
Current Income Taxes Payable	29.61	25.52	24.47	27.17	9.28
Current Unearned Revenue	15.1	22.93	1.34	4.25	11.13
Other Current Liabilities	33.07	35.37	23.78	28.79	12.8
Total Current Liabilities	349.11	205.87	131.37	151.5	116.07
Long-Term Leases	-	-	-	-	7.28
Long-Term Deferred Tax Liabilities	1.18	0.93	0.49	0.55	-
Other Long-Term Liabilities	5.26	0.56	0.02	0.02	0.12
Total Liabilities	355.54	207.36	131.88	152.07	123.47
Common Stock	896.8	891.63	889.34	846.99	769.99
Additional Paid-In Capital	331.29	326.93	296.1	281.9	264.39
Retained Earnings	534.5	344.12	244.46	169.8	110.3
Comprehensive Income & Other	-225	-187.56	-68.79	-3.04	-2.96
Total Common Equity	1,538	1,375	1,361	1,296	1,142
Shareholders' Equity	1,538	1,375	1,361	1,296	1,142
Total Liabilities & Equity	1,893	1,582	1,493	1,448	1,265
Total Debt	100	-	-	-	9.64
Net Cash (Debt)	776.19	639.05	431.08	799.76	517.51
Net Cash Growth	21.46%	48.24%	-46.10%	54.54%	161.86%
Net Cash Per Share	8.59	7.12	4.82	8.95	6.12
Filing Date Shares Outstanding	89.68	89.16	88.93	88.93	88.93
Total Common Shares Outstanding	89.68	89.16	88.93	88.93	88.93
Working Capital	772.36	624.47	488.19	841.75	667.49
Book Value Per Share	17.15	15.42	15.30	14.57	12.84
Tangible Book Value	1,537	1,375	1,361	1,294	1,140
Tangible Book Value Per Share	17.14	15.42	15.30	14.56	12.82
Land	133.23	133.23	133.23	133.23	133.23
Buildings	-	310.48	307.74	303.11	302.48
Machinery	542.5	181.24	160.52	149.88	162
Construction In Progress	13.01	20.08	17.67	21.6	18.79
Leasehold Improvements	13.43	13.43	18.91	18.91	23.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.